Vivoryon Therapeutics N.V. (AMS:VVY)
Netherlands · Delayed Price · Currency is EUR 1.070
-0.075 (-6.55%)
Jun 16, 2026, 5:35 PM CET
Vivoryon Therapeutics Market Cap
Vivoryon Therapeutics has a market cap or net worth of €33.91 million as of June 16, 2026. Its market cap has decreased by -23.03% in one year.
Market Cap
33.91M
Enterprise Value
28.40M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.07
Market Cap Chart
Since October 27, 2014, Vivoryon Therapeutics's market cap has decreased from 135.32M to 33.91M, a decrease of -74.94%. That is a compound annual growth rate of -11.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 15, 2026 | 33.91M | -19.37% |
| Dec 31, 2025 | 42.05M | -18.93% |
| Dec 31, 2024 | 51.87M | -75.55% |
| Dec 29, 2023 | 212.18M | -14.71% |
| Dec 30, 2022 | 248.77M | -34.70% |
| Dec 31, 2021 | 380.96M | 111.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Global InterConnection Group | 60.29M |
| Morefield Group | 58.28M |
| BM3EAC | 53.98M |
| Cabka | 49.42M |
| New Amsterdam Invest | 46.91M |
| Bever Holding NV | 42.99M |
| Ctac N.V. | 42.87M |
| Almunda Professionals | 25.17M |